GRACE THERAPEUTICS INC (GRCE) Stock Analyst Ratings

USA • Nasdaq • NASDAQ:GRCE • US00439U1043

3.67 USD
+0.04 (+1.1%)
Last: Feb 10, 2026, 08:11 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Buy % Consensus

83

ChartMill assigns a Buy % Consensus number of 83% to GRCE. The Buy consensus is the weighted average rating of the current analysts ratings.

  • Analysts have set a mean price target forecast of 11.9. This target is 224.25% above the current price.
  • GRCE was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about GRCE.
  • In the previous month the buy percentage consensus was at a similar level.
  • GRCE was analyzed by 8 analysts. More opinions would make the average more meaningful.

Related screens

Find peers with buy consensus above 85%
GRCE Historical Analyst RatingsGRCE Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8

Price Target & Forecast

Price Low Median Mean High 3.6711.1112.2411.9012.60 - 202.72% 233.51% 224.25% 243.32%

Related screens

Find peers 30% below price target
GRCE Current Analyst RatingGRCE Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4
Up and Down Grades
Date Firm Action Rating
2025-02-18 HC Wainwright & Co. Reiterate Buy -> Buy

GRACE THERAPEUTICS INC / GRCE FAQ

Can you provide the average price target for GRACE THERAPEUTICS INC stock?

8 analysts have analysed GRCE and the average price target is 11.9 USD. This implies a price increase of 224.25% is expected in the next year compared to the current price of 3.67.


What is the consensus rating for GRCE stock?

The consensus rating for GRACE THERAPEUTICS INC (GRCE) is 82.5 / 100 . This indicates that analysts generally have a positive outlook on the stock.